Care about R&D strategies? Have we got a summit for you
If there’s one underlying lesson I’ve learned watching biopharma in action over the past 20 years or so, it’s that no R&D organization can rest on its laurels. Especially the larger ones. You’ve had a big success? Great. Now how do you plan to follow up on that? And how soon? Hit by failure? What’s Plan B, C, D and E?
And that’s the central message of my upcoming European Biopharma Summit coming up next week. I’ll be talking to 5 top biopharma executives about their next-gen game plans.
This article is for premium subscribers only
Upgrade to a premium subscription plan for unlimited access, and join our community of key biopharma players.